Up until May 2024, Hikma supplied its generic injectable medicines to UK hospitals through a third-party distributor. Since then, Hikma PLC's UK affiliate, Hikma Pharmaceuticals International Limited (Hikma UK), now assumes direct responsibility for selling these products to the NHS for hospital use.

Our products cover various therapeutic areas: anti-infectives, oncology, anaesthesia, central nervous system, cardiology, etc. 

The marketing authorisations (MA) in the UK are owned by Hikma Farmacêutica (Portugal) S.A, and our products are mainly manufactured in Europe, where Hikma has three manufacturing plants (Portugal, Germany and Italy).